Search Results 11-20 of 16384 for infliximab

  1. A Study of the Relationship Between Infliximab Levels and the Rate of Colectomies in Patients who have Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to assess if infliximab drug levels in patients who have Ulcerative Colitis predict the risk of needing a colectomy. Additionally, ...

  3. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

    The purpose of this study is to develop a laboratory test to determine if an individual is at risk of developing antibodies to one of these two monoclonal ...

  4. Transcriptomic Changes Before And After Anti-tnf Therapy Utilizing Optimum Therapeutic Drug Levels - Mayo Clinic

    The purpose of this study is to evaluate infliximab drug levels and anti-infliximab antibody levels in HiSCR50/IHS4 responders versus non-responders at week 18.

  5. Research - 2008 Archives - Mayo Clinic News Network

    A study led by Mayo Clinic has found that infliximab (Remicade®) administered alone (monotherapy) or in combination with azathioprine is a more effective ...

  6. Gastroenterology

    Crohn's Disease Study on Infliximab, Azathioprine. Shawn Bishop. October 1, 2008. A study led by Mayo Clinic has found that infliximab (Remicade®) administered ...

  7. A Study To Collect Biospecimens (Blood, Stool And Intestinal Biopsies) To Support The Development Of Specific Biomarkers Of Treatment Response To Infliximab And Vedolizumab In Children With IBD - Mayo Clinic

    A Study To Collect Biospecimens (Blood, Stool And Intestinal Biopsies) To Support The Development Of Specific Biomarkers Of Treatment Response To Infliximab And ...

  8. Adalimumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    ... infliximab. It is also used to treat moderate to severe ulcerative colitis in adults and children 5 years of age and older who have been treated with other ...

  9. Inflammatory Bowel Disease (IBD) Clinical Trials - Mayo Clinic Research

    Our aim is to utilize these services in a small number of IBD patients to assess effectiveness of such services within a tertiary care practice. Infliximab ...

  10. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    Infliximab (Remicade), adalimumab (Humira) and certolizumab pegol (Cimzia). Also known as TNF inhibitors, these medicines work by neutralizing an immune ...